Recent Articles

• Kenmare Resources Reveals Payments to Governments for 2024
• Discover the JLT6015: A Game Changer in Rugged Computing
• Recent Share Buyback Announced by NB Private Equity Partners
• EGIDE Announces Temporary Transition to Penalty Bench Shares
• Foresight Group Shares Buyback Program: Key Insights and Update
• Kenmare Resources Expands Deadline for Consortium's Proposal
• Kenmare Resources Updates Share Capital Amid New Rules
• Cornish Metals' Bold Financial Updates for 2025 Take Center Stage
• Caledonia Mining's Update on Shareholder Changes and Impact
• SAGA Metals Welcomes Vernon Shein to Its Advisory Board
• Luke Ware Takes Leadership Role to Boost WTW's Asian Strategy
• Breakthrough Research Reveals Masitinib's Neuroprotective Powers
• APMH Invest Reveals Preliminary Results for Svitzer Shares
• SSI Schaefer Welcomes Koen Leekens as Senior Vice President
• Gaotu Techedu Delivers Strong Growth and New Buyback Plan
• Discover PROMISE Technology's Innovations in AI Storage Solutions
• Medications and Dry Mouth: Safeguarding Your Oral Health
• D-Link's AQUILA PRO AI M95: Award-Winning Smart Router Design
• PROMISE Technology Launches Advanced AI Storage Systems at Event
• How Online Auctions are Transforming Equipment Sales Growth
• Lobster Launches Data World to Transform Digital Ecosystems
• Empowering MVNOs: IPLOOK Leads the Charge for 2025 Connectivity
• Equinor ASA Begins Trading Ex-Dividend for Q4 2024 Cash Payout
• Bioretec's Q1 2025 Business Review: Growth and New Opportunities
• TomTom Partners with IFS to Boost Planning and Scheduling
• Iveco Group Reports Strong Foundation for Future Growth
• Positive Growth for Vallourec in 2025 First Quarter Results
• CROSSJECT’s ZENEO® Excels in Depth for Needle-Free Injections
• Endeavour Mining Engages in Strategic Share Repurchase
• Ensurge Micropower ASA Reports Successful 1Q 2025 Developments
• Hexagon Composites ASA Reports Q1 2025 Financial Results
• Revolutionary Advances in CAR-T Technology Unveiled by Immunofoco
• Bioretec's Q1 2025 Report: Growth and Future Prospects
• Foresee Pharmaceuticals Launches Phase 2 Study for Mirivadelgat
• NORBIT ASA Announces Award of Restricted Stock Units to Executives
• DNO ASA Reports Impressive Q1 Performance with Strategic Expansion
• Maison Reports Q1 2025 Sales Amidst Ongoing Market Challenges
• KBC Group Reports Strong 546 Million Euro First Quarter Profit
• Melexis Expands Board with Strategic Appointments for Growth
• Syensqo's Dynamic Q1 Performance and Strategic Outlook for 2025
• DNO ASA's Upcoming Dividend Payment Brings Excitement to Shareholders
• SBM Offshore Reports Strong Q1 2025 Performance Highlights
• Strategic Acquisition: KBC Expands with 365.bank Purchase
• Anbio Biotechnology Unveils Cutting-Edge Diagnostic Solutions
• itel City's Stylish and Durable Smartphone Redefines Budget Tech
• itel CITY 100: A Budget Smartphone with Premium Features
• Growing Demand for Personalized Tutoring Services in Europe
• Confronting Youth Unemployment: A Call for Action in Communities
• Anbio Biotechnology's Innovations Redefine Global Health Standards
• Cyclacel Pharmaceuticals: Q1 Financials and Future Outlook